Valeant Pharmaceuticals is planning sweeping changes to its board of directors as it moves to set a new tone at the top of a company under fire from politicians and investors for its management and drug-pricing practices.
WSJ.com: What's News US, Wall Street Journal
Wed, 04/27/2016 - 7:52pm
Valeant Pharmaceuticals is planning sweeping changes to its board of directors as it moves to set a new tone at the top of a company under fire from politicians and investors for its management and drug-pricing practices.